JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment
Yun Zhang(National Institutes of Health), Jörg H. W. Distler(Düsseldorf University Hospital), Christina Bergmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Clara Dees(Friedrich-Alexander-Universität Erlangen-Nürnberg), Oliver Distler(University Hospital of Zurich), Dirk Mielenz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Adam Reich(Rzeszów University of Technology), Andreas Ramming(Friedrich-Alexander-Universität Erlangen-Nürnberg), Georg Schett(Karolinska University Hospital), Chih‐Wei Chen(National Yang Ming Chiao Tung University), Ruifang Liang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tatjana Mallano(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alfiya Distler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Kolja Gelse(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 59
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699